In Vivo Fiber-Coupled Pre-Clinical Confocal Laser-scanning Endomicroscopy (pCLE) of Hippocampal Capillaries in Awake Mice
April 21st, 2023
1.3K views
Whereas multiphoton imaging is only effective at limited depths from the tissue’s surface, it is possible to achieve 3 µm resolution imaging at any depth via pCLE. Here, we present a protocol to conduct pCLE imaging to measure microvascular dynamics in the hippocampus of ictal and wild-type mice.
Overview
This study presents a protocol for performing pCLE imaging to measure microvascular dynamics in the hippocampus of mice, enabling high-resolution imaging at any depth. The technique enhances simultaneous imaging and electrophysiological recordings from neural structures in vivo, aiming to investigate functional vascular abnormalities.
Key Study Components
Area of Science
- Neuroscience
- Imaging techniques
- Vascular dynamics
Background
- Existing imaging methods, like multiphoton imaging, have depth limitations.
- pCLE can achieve 3 µm resolution at any tissue depth.
- This technique is important for studying vascular health in neurological conditions.
Purpose of Study
- To demonstrate a protocol for pCLE imaging to evaluate blood flow dynamics within the hippocampus.
- To investigate the role of vascular abnormalities in epilepsy and age-related conditions.
- To allow functional studies without the need for deep anesthesia.
Methods Used
- pCLE imaging with a confocal laser-scanning fiber-optic endomicroscope.
- Animal model: awake or relatively anesthetized mice.
- Detailed surgical methodology for head cap implantation and electrode placement.
- Injecting fluorescein to visualize blood flow for imaging.
Main Results
- This approach allowed for detailed visualization of blood flow in deep brain microvessels.
- Demonstrated that blood flow stoppages occur at labeled mural cells.
- Facilitated comparisons with high-resolution two-photon imaging to identify vascular responses.
Conclusions
- The study demonstrates a viable technique for analyzing microvascular dynamics in vivo.
- It has implications for understanding blood flow pathology in neurological diseases.
- Enhances the ability to study vascular contributions to neural function and dysfunction.
Frequently Asked Questions
What are the advantages of using pCLE imaging?
pCLE imaging allows high-resolution imaging at any depth, outperforming traditional methods like multiphoton imaging.
How is the pCLE imaging method implemented in animal models?
The method involves a surgical procedure to implant a head cap and electrodes, ensuring stable positioning for imaging.
What types of outcomes can be obtained from this technique?
This technique provides detailed imagery of blood flow within brain microvessels, key for understanding vascular dynamics.
How can the pCLE imaging technique be adapted for other studies?
The technique can be utilized for in vivo studies across various organs, including the retina, not limited to neural tissue.
Are there any key limitations of this technique?
Care must be taken during the surgical procedure to minimize risk, and the technique requires precise handling of the imaging equipment.
What kind of biological responses can be monitored using this imaging method?
The imaging method can monitor dynamic blood flow changes, which are crucial for understanding vascular responses under different conditions.
Executive Industry Relevance
This protocol enables real-time imaging of microvascular dynamics in deep brain structures, supporting target validation in neurological disease models. By allowing simultaneous electrophysiological and vascular recordings in awake animals, it reduces confounding effects of anesthesia and improves predictive confidence in preclinical studies. The approach addresses a critical gap in studying vascular contributions to neural dysfunction, relevant for de-risking targets in epilepsy and neurodegenerative disease pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses linking vascular dysfunction to neural activity in disease models.
- Operational Value: Provides functional validation of mural cell-mediated capillary constriction as a mechanistic biomarker.
- Predictive Value: Supports target confidence by visualizing real-time vascular responses to pharmacological or genetic interventions.
Screening & Assay Development
- Assay Readiness: Prepares standardized biological systems for evaluating compound effects on cerebral blood flow dynamics.
- Quantitative Output: Generates measurable parameters such as vessel diameter changes and flow stoppage frequency at mural cells.
- Reproducibility: Stabilizes imaging conditions over several hours, enabling longitudinal screening campaigns.
Translational & Preclinical Research
- Disease Relevance: Directly models hippocampal capillary pathology observed in epilepsy and vascular cognitive impairment.
- Translational Continuity: Bridges discovery-phase vascular mechanisms to preclinical efficacy assessment of vasomodulatory therapies.
- Risk-Adjusted Decisions: Informs go/no-go criteria by quantifying vascular rescue or exacerbation in response to treatment.
Pipeline & Workflow Integration
The method fits within the discovery-to-preclinical continuum by providing functional vascular readouts that inform target selection and lead optimization.
- Discovery Biology: Supports hypothesis testing of neurovascular coupling mechanisms in awake, behaving animals.
- Screening: Enables assay-ready preparation for evaluating vasoactive compounds in disease-relevant microvascular networks.
- Analytics: Delivers quantitative, spatially resolved blood flow metrics that facilitate comparison across experimental conditions.
- Translational Research: Connects microvascular dysfunction in hippocampus to downstream neural degeneration pathways.
- Enterprise Reuse: Establishes a reusable platform for studying vascular contributions across multiple CNS disease models.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity by directly visualizing pericyte-mediated capillary dynamics in vivo.
- Operational Value: Standardizes head-restraint and imaging procedures for reproducible, long-duration recordings.
- Strategic Value: Improves capital efficiency by enabling early detection of vascular liabilities in lead candidates.
- Portfolio Impact: Enhances risk-adjusted prioritization by integrating vascular health into target validation cascades.
Implementation Considerations
- Requires expertise in stereotaxic surgery, cranial window preparation, and vascular injection techniques.
- Depends on access to confocal laser-scanning endomicroscopes and compatible fiber-optic probes.
- Necessitates standardization across surgical and imaging teams to ensure consistent window placement and electrode positioning.
- Adaptation to other organ systems (e.g., retina) requires validation of vascular labeling and imaging depth parameters.
- Practical limitations include surgical morbidity risk and the need for post-operative monitoring to maintain animal welfare and data quality.
Biopharma FAQs
Why does measuring capillary flow stoppage matter for target validation?
Quantifying flow cessation at mural cells provides a functional readout of pericyte-mediated vasoconstriction, which is mechanistically linked to neural hypoperfusion in epilepsy models. This measurement enables objective assessment of vascular target engagement by pharmacological agents. It supports go/no-go decisions by linking target modulation to downstream physiological effects in vivo.
How does isolating the independent variable of neural activity improve discovery pipeline efficiency?
By using awake animal preparations, the protocol minimizes anesthetic confounds that can independently alter vascular tone and neural firing. This isolation allows clearer attribution of vascular changes to specific neural stimuli or disease states. It increases predictive confidence in target validation by reducing variability in neurovascular coupling measurements.
What quantitative dependent variable measurements enable preclinical decision-making?
The technique generates measurable outputs such as capillary diameter fluctuations, red blood cell velocity, and frequency of flow stoppages at labeled mural cells. These parameters serve as dose-responsive biomarkers for evaluating vasoactive compounds. Thresholds for meaningful change can be established to inform lead optimization and toxicity screening.
Why do replication requirements matter for cross-functional collaboration in vascular studies?
Consistent replication across animals and sessions ensures that observed vascular responses are robust and not attributable to surgical variability or handling stress. This reliability is essential when transferring data between discovery biology, pharmacology, and toxicology teams. Standardized protocols enable alignment on efficacy thresholds and safety margins across functional domains.
What statistical analysis capabilities are required before implementing this method in a discovery workflow?
Implementation requires the ability to perform time-series analysis of vascular dynamics, including event detection for flow stoppages and correlation with electrophysiological signals. Teams must be equipped to handle longitudinal data from multi-hour recordings and apply appropriate corrections for multiple comparisons. Access to image quantification tools and blinded analysis workflows is necessary to ensure objective, reproducible readouts.
Chapters in this video
0:05
Introduction
1:18
Stereotaxic Positioning
3:27
Head-Cap Installation
4:33
Imaging Window
5:55
In Vivo Fiber-Optic-Bundle-Coupled Pre-Clinical Confocal Laser-Scanning Endomicroscopy (pCLE)
7:27
Results: Representative Mural Cell Vasoconstriction and Recorded Brain Immunohistochemistry
8:26
Conclusion
